A detailed history of Pale Fire Capital Se transactions in Verve Therapeutics, Inc. stock. As of the latest transaction made, Pale Fire Capital Se holds 44,800 shares of VERV stock, worth $275,968. This represents 0.06% of its overall portfolio holdings.

Number of Shares
44,800
Previous 45,600 1.75%
Holding current value
$275,968
Previous $221 Million 14.48%
% of portfolio
0.06%
Previous 0.03%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
$4.5 - $7.19 $3,600 - $5,752
-800 Reduced 1.75%
44,800 $253 Million
Q3 2024

Nov 12, 2024

BUY
$4.4 - $7.86 $200,640 - $358,416
45,600 New
45,600 $221 Million

Others Institutions Holding VERV

About Verve Therapeutics, Inc.


  • Ticker VERV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,942,300
  • Market Cap $369M
  • Description
  • Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Its lead product candidate is VERVE-101, a single-course gene editing treatment that permanently turns off the PCSK9 gene in the liver. The company also engages in the development of ANGPTL3 program t...
More about VERV
Track This Portfolio

Track Pale Fire Capital Se Portfolio

Follow Pale Fire Capital Se and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pale Fire Capital Se, based on Form 13F filings with the SEC.

News

Stay updated on Pale Fire Capital Se with notifications on news.